Amherst Pharmaceuticals is a commercial-stage specialty pharmaceutical company having a core capability to commercialize innovative primary care products.
BETTER SLEEP THROUGH INNOVATION
Our lead product, Zolpimist® Oral Spray, is the only FDA approved product that delivers a fine mist spray of zolpidem tartrate, the most widely prescribed agent in the US for treating insomnia. Zolpimist® is sprayed over the tongue and onto the back of the mouth. Zolpimist® is not inhaled. Due to its rapid absorption, Zolpimist® should only be administered immediately before sleep is desired. Patients should use Zolpimist® when they expect to be able to stay in bed for a full night (7-8 hours).